Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE had been pointlessly carried out repeatedly. It...

Full description

Bibliographic Details
Main Authors: Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2020-04-01
Series:Clinical and Molecular Hepatology
Subjects:
carcinoma, hepatocellular
liver neoplasms
patient selection
sorafenib
Online Access:http://e-cmh.org/upload/pdf/cmh-2019-0021n.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2019-0021n.pdf

Similar Items